70M mkt Cap, 60M cash which allow them for 2 more years of R&D. And the Contract(s) for 4 development with Glaxo may bring them 800M : (it means if Glaxo is having success to co-develop with them, and can licence the products : it works always this way in biotech/biopharm: you improve data/research and you can sell it to other co to continue to develop: it is seen a like a technology patent) .
Glaxo pay Royalties if one product comes to complete fruition and be on commercialization....but this is the ultimate success a co can dream for.
.At the chart side, this stuff is what is out of my model i can 'master'. But the intraday may give it a lightly bullish trend. Nevertheless nothing too obvious, too excitant.
But what do i know, as this chart pattern is not what i can guess a lot.
Cross finger untill i flip and find better stocks.
Of course i wish to see this stock in the 200M mkt cap instead of being only 70Mkt cap even at +569% gain yesteday.
News 
Market Data 
Discover 
AI
